Matthew S. Milak

Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial

Michael F. Grunebaum, Hanga Galfalvy, Tse‐Hwei Choo et al. · American Journal of Psychiatry · 2017 · 427 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +16

Neuroanatomic Correlates of Psychopathologic Components of Major Depressive Disorder

Matthew S. Milak, Ramin V. Parsey, John G. Keilp et al. · Archives of General Psychiatry · 2005 · 178 citations

Medicine, Neuroscience, Psychiatry +17

Higher Serotonin 1A Binding in a Second Major Depression Cohort: Modeling and Reference Region Considerations

Ramin V. Parsey, R. Todd Ogden, Jeffrey M. Miller et al. · Biological Psychiatry · 2010 · 174 citations · Full text

Medicine, Neuroscience, Psychiatry +16

Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam‐controlled randomized clinical trial

Michael F. Grunebaum, Steven P. Ellis, John G. Keilp et al. · Bipolar Disorders · 2017 · 174 citations

Medicine, Pharmacology, Psychiatry +13

A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder

Matthew S. Milak, Carol J. Proper, Stephanie Mulhern et al. · Molecular Psychiatry · 2015 · 142 citations

Life Sciences, Neuroscience, Pharmacology +14